Меню
Набор скоро начнётся NCT07739563

EXERT-BC Cardio: Cardio or Conditioning Training With Breast Cancer

Без фазы С лечением Cancer Breast Cancer

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Resistance Training with Cardio, Resistance Training with Conditioning.
Кому может быть актуально
Состояния в реестре: Cancer, Breast Cancer. Базовые параметры: 20 лет — 89 лет · Женщины.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
США
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Не всё понятно в терминах? Прочитайте наш гид для пациентов →

Официальное название

EXERT-BC Cardio: Randomized Study of EXErcise Regimens After Treatment for Breast Cancer Utilizing Cardio or Conditioning Training

Обзор

In this study, the investigators hypothesize that observed intense resistance training with conditioning elicits similar changes in body composition, muscle mass, and blood pressure as that with cardiovascular training (or cardio) for women treated with breast cancer.

Вмешательства

  • Поведенческое Resistance Training with Cardio
    Participants in this arm will engage in a supervised exercise regimen three times per week, for approximately 2 months (8 weeks). The regimen combines two days of hypertrophy-focused resistance training with a third day dedicated to steady-state cardiovascular exercise. The cardio day will utilize ergometer-based exercises (rowing ergometer, Assault Air Bike) and unweighted sled pushes, with each activity lasting 10 minutes continuously. The overall program aims to improve cardiorespiratory fitn
  • Поведенческое Resistance Training with Conditioning
    Participants in this arm will engage in a supervised exercise regimen three times per week, for approximately 2 months (8 weeks). The regimen combines two days of hypertrophy-focused resistance training with a third day dedicated to high-intensity conditioning. The conditioning day involves a circuit format of 6 total exercises, completed for 8 repetitions each across 8 sets, with limited rest periods (10 seconds or less) between exercises and sets. Exercise selection is total-body focused, alte

Первичные конечные точки

  • Change in Muscle Mass [Срок оценки: Baseline (Prior to Program) and At Exercise Program Completion (approximately 2 months).]
  • Change in Fat Mass [Срок оценки: Baseline (Prior to Program) and At Exercise Program Completion (approximately 2 months).]
Вторичные конечные точки (6)
  • Change in Blood Pressure [Срок оценки: Baseline (Prior to Program), at Month 1, and At Exercise Program Completion (approximately 2 months).]
  • Change in Resting Metabolic Rate [Срок оценки: At Exercise Program Completion (approximately 2 months).]
  • Change in Body Composition Metrics (Other than Muscle/Fat Mass) [Срок оценки: Baseline (Prior to Program) and At Exercise Program Completion (approximately 2 months).]
  • Change in Phase Angle [Срок оценки: Baseline (Prior to Program) and At Exercise Program Completion (approximately 2 months).]
  • Exercise Adherence [Срок оценки: Throughout the Exercise Program (approximately 2 months).]
  • Change in Grip Strength [Срок оценки: Baseline (Prior to Program), During Exercise Program (before and after each workout), and At Exercise Program Completion (approximately 2 months).]

Критерии участия

Критерии включения

  • Age 20-89 years
  • Women prescribed exercise as a SOC
  • Women with a biopsy proven diagnosis of ductal carcinoma in situ (DCIS) or invasive carcinoma of the breast
  • Women must have undergone treatment for breast cancer, including one or more of the following: surgery, radiation therapy, chemotherapy, immunotherapy, or hormonal therapy. Women undergoing active chemotherapy are not allowed on study. Immunotherapy or targeted agent usage is allowed.
  • Women with > 3 months of resistance training experience under expert guidance by a CSCS
  • Must be able to read and understand English and consent for themselves.

Критерии исключения

  • Any current treatment with cytotoxic chemotherapy for breast cancer
  • Inability to safely engage in group sessions of resistance training as deemed by study PI
  • Severe arthritic, joint, cardiovascular, or musculoskeletal condition deemed by PI to be unsafe to engage in resistance training
  • Beta blocker or GLP-1 inhibitor medications
  • Pregnant women
  • Males

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Открытое
Основная цель
Другое

Центры проведения

США · 1 центр
  • AHN Allegheny General Hospital — Pittsburgh

Идентификаторы

NCT: NCT07739563 · 2026-195

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗